Efficacy and safety of acetyl-CoA carboxylase (ACC) inhibitors in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review.
Liubin XuHuili YangHongling XuRong YangLian FenDansheng JiangLinyi XuYu-Feng XingPublished in: Medicine (2022)
The conclusion of this systematic review will achieve convincing evidence to evaluate the efficacy and safety of ACC inhibitors for NASH.